Richard R. Gammon

Dr. Richard R. Gammon

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2020 in Transfusion
Verified
Journal Article
Closed access
PDF file
RGRichard R. Gammon
Richard R. Gammon
LRLizabeth Rosenbaum
Lizabeth Rosenbaum
RCRhonda Cooke
Rhonda Cooke
MFMark Friedman
Mark Friedman
LRLinda Rockwood
Linda Rockwood
SVSarah Vossoughi
Sarah Vossoughi

9 May 2023 in Expert Review of Hematology
Verified
Journal Article
Closed access
TDTayler A. Van Denakker
Tayler A. Van Denakker
AAArwa Z. Al-Riyami
Arwa Z. Al-Riyami
RFRita Feghali
Rita Feghali
RGRichard R. Gammon
Richard R. Gammon
CSCynthia So-Osman
Cynthia So-Osman
EBEvan M. Bloch
Evan M. Bloch
The COVID-19 pandemic has resulted in a historic public health crisis with widespread social and economic ramifications. The pandemic has also affected the blood supply resulting in unprecedented a...

19 July 2021 in Transfusion
Verified
Journal Article
Closed access
SPSuchitra Pandey
Suchitra Pandey
GBGeoffrey A. Belanger
Geoffrey A. Belanger
SRSrijana Rajbhandary
Srijana Rajbhandary
CCClaudia S. Cohn
Claudia S. Cohn
RBRichard J. Benjamin
Richard J. Benjamin
RGRichard R. Gammon
Richard R. Gammon

1 November 2023 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
RGRichard R. Gammon
Richard R. Gammon
RDRounak Dubey
Rounak Dubey
GGGaurav K Gupta
Gaurav K Gupta
CHColleen Hinrichsen
Colleen Hinrichsen
AJAikaj Jindal
Aikaj Jindal
CBChristopher Bocquet
Christopher Bocquet
Blood donors and voluntary blood donations are essential for ensuring the blood supply that can be maintained by good patient blood management (PBM) practices. This review article explores the role of blood donation in PBM and highlights the importance of donor screening and selection processes in different regions worldwide. The donor health questionnaires and the focused physical examination guidelines have changed in the last decade to increase donor and recipient safety. This article also discusses the status of transfusion practices, including the challenges of ensuring a safe blood supply. Significant among these are the effects of the COVID-19 pandemic on the blood supply chain and the impact of an aging donor population, especially. Promoting autologous donations and other blood conservation strategies are suggested to mitigate these issues. The role of replacement donors and the upper age limit for voluntary blood donation may be decided based on the demography and donor pool. The involvement of C-suite executives is also critical in implementing and running a successful PBM program. The review highlights how these different aspects of blood donation are integral to a successful PBM program and the safety of patients who receive blood transfusions.

10 February 2021 in Transfusion
Verified
Journal Article
Closed access
PDF file
RGRichard R. Gammon
Richard R. Gammon
APAlicia Bellido Prichard
Alicia Bellido Prichard
MGMichael Sel Gannett
Michael Sel Gannett
BYBoyan Yordanov
Boyan Yordanov

20 December 2021 in Transfusion
Verified
Journal Article
Open access
PDF file
RGRichard R. Gammon
Richard R. Gammon
RRRita A. Reik
Rita A. Reik
MSMarc Stern
Marc Stern
RVRalph R. Vassallo
Ralph R. Vassallo
DWDan A. Waxman
Dan A. Waxman
RBRichard J. Benjamin
Richard J. Benjamin
Background: Apheresis platelets (AP) may be contaminated by environmental bacteria via container defects acquired during processing, transport, storage, or transfusion, as highlighted by a recent series of septic reactions related to Acinetobacter spp. and other bacterial strains.Study design and methods: The frequency and nature of acquired container defect reports to one manufacturer were evaluated from January 2019 to July 2020. The published incidence of contamination and sepsis due to environmental bacteria with culture screened AP in the United States was reviewed for the period of 2010–2019.Results: Review of a manufacturers' records showed 23 US reports of leaks involving 24 containers attributed to postmanufacturing damage, at a rate of 44 per million distributed storage containers. Analysis of returned containers showed evidence of scratches, impressions, and/or piercings. Literature review of US hemovigilance data revealed that environmental bacteria comprised 7% of confirmed positive primary bacterial culture screens, were responsible for 14%–16% of reported septic, and 8 of 28 (29%) fatal reactions with bacterial‐culture screened AP. Sepsis cases have been reported with culture screened, point‐of‐issue (POI) tested, or pathogen‐reduced AP.Discussion: Environmental contamination of AP is rare but can cause sepsis. Container damage provides a pathway for contamination after culture screening, POI bacteria testing, or pathogen reduction. Blood collectors and transfusion services should have procedures to ensure proper inspection, handling, storage, and transport of AP to avoid damage and should enhance efforts to detect defects prior to release and to eliminate bacteria from all contacting surfaces to minimize the risk of contamination.